Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Hepatitis

Free Subscription Articles published in Int J Cancer Retrieve available abstracts of 10 articles: HTML format

Single Articles

March 2023
1. PETRICK JL, Florio AA, Zen J, Wang Y, et al
   Biomarkers of gut barrier dysfunction and risk of hepatocellular carcinoma in the REVEAL-HBV and REVEAL-HCV Cohort Studies.
   Int J Cancer. 2023 Mar 6. doi: 10.1002/ijc.34492.
   PubMed     Abstract available
   
   
   July 2022
2. FU P, Gong B, Li H, Luo Q, et al
   Combined identification of three lncRNAs in serum as effective diagnostic and prognostic biomarkers for hepatitis B virus-related hepatocellular carcinoma.
   Int J Cancer. 2022 Jul 8. doi: 10.1002/ijc.34201.
   PubMed     Abstract available
   
   
   May 2022
3. LIU T, Shi H
   Reply to: Comment on "Hepatitis B virus infection and the risk of gastrointestinal cancers among Chinese population: a prospective cohort study".
   Int J Cancer. 2022 May 10. doi: 10.1002/ijc.34113.
   PubMed    
   
   
   
4. YANG Y, Chen XZ
   Comment on: "Hepatitis B virus infection and the risk of gastrointestinal cancers among Chinese population: a prospective cohort study".
   Int J Cancer. 2022 May 10. doi: 10.1002/ijc.34114.
   PubMed    
   
   
   April 2022
5. CHEN S, Gao Y, Wang Y, Daemen T, et al
   The Combined Signatures of Hypoxia and Cellular Landscape Provides a Prognostic and Therapeutic Biomarker in HBV-Related Hepatocellular Carcinoma.
   Int J Cancer. 2022 Apr 25. doi: 10.1002/ijc.34045.
   PubMed     Abstract available
   
   
   December 2021
6. LIU T, Song C, Zhang Y, Siyin ST, et al
   Hepatitis B virus infection and the risk of gastrointestinal cancers among Chinese population: a prospective cohort study.
   Int J Cancer. 2021 Dec 2. doi: 10.1002/ijc.33891.
   PubMed     Abstract available
   
   
   June 2021
7. JI XW, Wang J, Shen QM, Li ZY, et al
   Dietary fat intake and liver cancer incidence: A population-based cohort study in Chinese men.
   Int J Cancer. 2021;148:2982-2996.
   PubMed     Abstract available
   
   
   
8. YU C, Song C, Lv J, Zhu M, et al
   Prediction and clinical utility of a liver cancer risk model in Chinese adults: A prospective cohort study of 0.5 million people.
   Int J Cancer. 2021;148:2924-2934.
   PubMed     Abstract available
   
   
   
9. JAQUET A, Boni SP, Boidy K, Tine J, et al
   Chronic viral hepatitis, HIV infection and Non-Hodgkin lymphomas in West Africa, a case-control study.
   Int J Cancer. 2021 Jun 14. doi: 10.1002/ijc.33709.
   PubMed     Abstract available
   
   
   March 2021
10. SHI JF, Cao M, Wang Y, Bai FZ, et al
    Is it possible to halve the incidence of liver cancer in China by 2050?
    Int J Cancer. 2021;148:1051-1065.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: